|
|
|
|
Clinical Pharmacology Group, University of Southampton, Biomedical Sciences Building, Southampton SO16 7PX, UK
2 To whom correspondence should be addressed. E-mail: agr{at}soton.ac.uk.
The risk assessment of compounds added to foods or taken as supplements is usually based on hazard characterization studies performed in animal test species. A large default uncertainty factor, or margin or exposure, is usually required to allow for possible species differences and human variability in the toxicokinetics and toxicodynamics of the compound. The development of biomarkers offers the potential to rationalize the risk assessment of amino acids, and to refine the extrapolation of data from animals to humans. The use of high resolution nuclear magnetic resonance spectroscopy applied to readily accessible biological fluids, such as urine and plasma, offers great potential for the identification of toxicologically relevant biomarkers in animal studies that can then be applied to studies in humans.
KEY WORDS: amino acids risk assessment biomarkers metabonomics toxicokinetics
This article has been cited by other articles:
![]() |
L. Cynober Introduction to the 5th Amino Acid Assessment Workshop. J. Nutr., June 1, 2006; 136(6 Suppl): 1633S - 1635S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Toue, R. Kodama, M. Amao, Y. Kawamata, T. Kimura, and R. Sakai Screening of Toxicity Biomarkers for Methionine Excess in Rats J. Nutr., June 1, 2006; 136(6): 1716S - 1721S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Rand Variability in Planning and Assessment: Statistical Considerations and Models J. Nutr., June 1, 2004; 134(6): 1610S - 1616S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sakai, M. Miura, M. Amao, R. Kodama, S. Toue, Y. Noguchi, and T. Kimura Potential Approaches to the Assessment of Amino Acid Adequacy in Rats: A Progress Report J. Nutr., June 1, 2004; 134(6): 1651S - 1655S. [Abstract] [Full Text] [PDF] |
||||